HR 449 · 115th Congress 2017–2019, ended

Synthetic Drug Awareness Act of 2018

Latest action · Jun 13, 2018 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 11, 2017
  2. Passed HouseJun 12, 2018
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Synthetic Drug Awareness Act of 2017

This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").

Cosponsors 47

Members who signed on, in the order they did. Signatures ran from Jan 11, 2017 to Jun 12, 2018; 4 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-NYChris CollinsOriginalJan 11, 2017
D-NCG. K. ButterfieldOriginalJan 11, 2017
R-PAPatrick MeehanOriginalJan 11, 2017
R-SCTrey GowdyOriginalJan 11, 2017
R-WIF. James Sensenbrenner, Jr.Feb 9, 2017
R-NDKevin CramerFeb 17, 2017
R-NYDaniel M. Donovan, Jr.Feb 21, 2017
R-NYElise M. StefanikFeb 21, 2017
R-TXMac ThornberryFeb 24, 2017
R-FLGus M. BilirakisFeb 27, 2017
R-FLThomas J. RooneyFeb 27, 2017
R-NYPeter T. KingFeb 28, 2017
R-OHDavid P. JoyceMar 6, 2017
R-GARick W. AllenMar 6, 2017
R-OKMarkwayne MullinMar 16, 2017
D-NHAnn M. KusterMar 27, 2017
R-TXPete OlsonMar 27, 2017
R-WVDavid B. McKinleyMar 29, 2017
R-VABarbara ComstockMay 2, 2017
D-DELisa Blunt RochesterJun 26, 2017
R-ILRodney DavisJun 27, 2017
D-ILBobby L. RushJun 29, 2017
R-PABrian K. FitzpatrickJun 29, 2017
R-WVEvan H. JenkinsJun 29, 2017
R-CAMimi WaltersJun 29, 2017
R-NJThomas MacArthurJun 29, 2017
D-NYYvette D. ClarkeJun 29, 2017
D-NJDonald NorcrossJul 10, 2017
R-MITim WalbergJul 10, 2017
D-NYEliot L. EngelJul 11, 2017
D-NYPaul TonkoJul 13, 2017
D-CAScott H. PetersJul 13, 2017
D-CATony CárdenasJul 13, 2017
D-CAAnna G. EshooJul 26, 2017
D-NMBen Ray LujánJul 27, 2017
D-CARaul RuizJul 28, 2017
D-ILRaja KrishnamoorthiSep 6, 2017
D-CARo KhannaSep 26, 2017
D-CAMark DeSaulnierOct 12, 2017
R-NYJohn J. FasoDec 19, 2017
D-NHCarol Shea-PorterJan 29, 2018
D-NYLouise McIntosh SlaughterFeb 13, 2018
R-TNMarsha BlackburnMay 9, 2018
R-ORGreg WaldenMay 22, 2018
R-ILMike BostMay 22, 2018
R-FLBill PoseyJun 1, 2018
D-WADerek KilmerJun 12, 2018

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jan 11, 2017Markup May 9, 2018
Health Subcommittee
Referred Jan 25, 2017Markup Apr 25, 2018Reported Apr 25, 2018
SenateHealth, Education, Labor, and Pensions Committee
Referred Jun 13, 2018

Actions 14

Everything that happened, newest first.

  1. Jun 13, 2018Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Jun 12, 2018Mr. Latta moved to suspend the rules and pass the bill, as amended.
  3. Jun 12, 2018Considered under suspension of the rules. (consideration: CR H5029-5031)
  4. Jun 12, 2018DEBATE - The House proceeded with forty minutes of debate on H.R. 449.
  5. Jun 12, 2018Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

In the Congressional Record 2

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
ExtensionsDebate and remarks E977Sheila Jackson Lee D-TXJul 6, 2018
HouseDebate and remarks H5029–H5031Text printed H5029Frank Pallone, Jr. D-NJ, Greg Walden R-OR, Hakeem S. Jeffries D-NY, Robert E. Latta R-OH, Sheila Jackson Lee D-TXJun 12, 2018

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Congressional Budget Office cost estimate

  1. Jun 7, 2018H.R. 449, Synthetic Drug Awareness Act of 2018As ordered reported by the House Committee on Energy and Commerce on May 9, 2018

Constitutional authority

Congress has thepower to enact this legislation pursuant to the following: Article I, Section 8, Clause 18 of the United States Constitution(``Congress shall have the power . . . To make all Laws which shall be necessary and proper for carrying into Execution . . .all other Powers vested in this Constitution in the Government of the United States, or in any Department or Officerthereof).

The sponsor’s statement, as printed in the Congressional Record, vol. 163, no. 7, January 11, 2017, page H392.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 115-112COMBATING THE OPIOID CRISIS: PREVENTION AND PUBLIC HEALTH SOLUTIONS573 pagesEnergy and Commerce CommitteeMar 21, 2018–Mar 22, 2018
Serial No. 115-64MEMBER DAY: TESTIMONY AND PROPOSALS ON THE OPIOID CRISIS167 pagesEnergy and Commerce CommitteeOct 11, 2017

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 6SUPPORT for Patients and Communities ActRelated billOct 24, 2018
S 3356Synthetic Drug Awareness Act of 2018Related billAug 21, 2018
HR 5020Synthetic Drug Awareness Act of 2016Reintroduction ofApr 22, 2016

Titles 4

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require the Surgeon General of the Public Health Service to submit to Congress a report on the effects on public health of the increased rate of use of synthetic drugs.
Official Titles as Amended by House
To require the Surgeon General of the Public Health Service to submit to Congress a report on the health effects of new psychoactive substances (including synthetic drugs) use.
Short Titles as Introduced
Synthetic Drug Awareness Act of 2017
Short Titles as Passed House
Synthetic Drug Awareness Act of 2018

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 3

Each version as it was printed, newest first.

  1. Jun 13, 2018Referred in Senate
  2. Jun 12, 2018Engrossed in House
  3. Jan 11, 2017Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.